Abstract LB098: Deep plasma proteome characterization in two independent clinical cohorts identifies clusters of biomarkers separating benign and malign tumors in women with suspicion of ovarian cancer

卵巢癌 医学 癌症 内科学 肿瘤科 蛋白质组 病理 生物信息学 生物
作者
Stefan Enroth,M Moskov,Julia Lindberg Hedlund,Svetlana N. Popova,Simn K. Forsberg,Klev Diamanti,Maria Lycke,Emma Ivansson,Anna Tolf,Karin Sundfeldt,Karin Stålberg,Ulf Gyllensten
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (7_Supplement): LB098-LB098
标识
DOI:10.1158/1538-7445.am2024-lb098
摘要

Abstract Early detection is essential for ovarian cancer survival but today’s biomarkers are not specific enough to clear benign from malignant tumors nor sensitive enough to be used in screening. Here we have used the proximity extension assay (PEA) Olink Explore HT to characterize 5416 plasma proteins. For a subset of the women, we have also characterized the transcriptional landscape in corresponding tumor tissue using total RNA-sequencing on the Illumina NovaSeq 6000 instrument. The plasma samples were from two independent Swedish clinical cohorts (N1 = 171, N2 = 233) and tumor RNA was extracted from 112 of the samples from the second cohort. Each cohort consisted of women who after suspicion of ovarian cancer were surgically diagnosed with either benign or malign tumors. All plasma samples were collected at time of diagnosis, before commencement of treatment. In the plasma protein analyses, the first cohort was used as a discovery and the second as replication. In the discovery cohort, we found a total of 328 plasma proteins differing significantly between women with benign tumors and; early stage (I-II), late stage (III-IV) or any stage(I-IV) malignant tumors. These associations were examined in the replication cohort, and were all found to have similar foldchange between women with benign and malignant tumors. 99.7% (327/328) differed significantly after adjustment for multiple hypothesis testing. The 328 associations corresponded to a total of 192 proteins out of which 26 (13.5%) were found to have a significant correlation with RNA-expression in the corresponding tumor. A correlation network analysis based on the 192 proteins identified 5 major clusters, consisting of 18 to 59 protein-protein couplings. 80% of these clusters contained proteins that are annotated with up to five major KEGG cancer pathways and several of these contained proteins correlating significantly with the tumor RNA-SEQ data. All except one cluster contained one or two proteins that are either currently approved FDA drug targets or listed as druggable in DrugBank by specific compounds. Ovarian cancer has a low 5-year survival and eludes the current treatment regimens if discovered late. By applying high-throughput proteomics in two independent cohorts, we identified a large number of affected proteins out of which only a few have corresponding changes in tumor RNA-expression. We also identified large highly co-regulated networks of proteins, suggesting large downstream systemic effects which could be a contributing factor to the difficulties in finding efficient treatments. Among these proteins, there are several druggable targets, however, not all the associated compounds are currently primarily used as anti-cancer drugs, highlighting the possibility of drug re-purposing for future use against ovarian cancer. Citation Format: Stefan Enroth, Mikaela Moskov, Julia Lindberg Hedlund, Svetlana Popova, Simn K. Forsberg, Klev Diamanti, Maria Lycke, Emma Ivansson, Anna Tolf, Karin Sundfeldt, Karin Stålberg, Ulf Gyllensten. Deep plasma proteome characterization in two independent clinical cohorts identifies clusters of biomarkers separating benign and malign tumors in women with suspicion of ovarian cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl):Abstract nr LB098.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
普鲁卡因发布了新的文献求助10
2秒前
Liang完成签到,获得积分10
3秒前
爱思考的小笨笨完成签到,获得积分10
4秒前
123456完成签到 ,获得积分10
4秒前
小飞完成签到 ,获得积分10
5秒前
俞斐完成签到,获得积分10
6秒前
我超爱cs完成签到,获得积分10
6秒前
爱因斯坦那个和我一样的科学家完成签到,获得积分10
13秒前
彭a完成签到,获得积分10
13秒前
Migrol完成签到,获得积分10
14秒前
高兴的小完成签到,获得积分10
14秒前
蕉鲁诺蕉巴纳完成签到,获得积分0
16秒前
慕青应助普鲁卡因采纳,获得10
16秒前
御剑乘风来完成签到,获得积分10
16秒前
李牛牛完成签到,获得积分10
20秒前
等待的代容完成签到,获得积分10
22秒前
传奇3应助小南孩采纳,获得10
22秒前
尊敬飞丹完成签到,获得积分10
23秒前
25秒前
离岸完成签到,获得积分10
25秒前
tian完成签到,获得积分10
27秒前
普鲁卡因发布了新的文献求助10
29秒前
daijk完成签到,获得积分10
30秒前
32秒前
风趣的烨磊完成签到,获得积分10
35秒前
仝富贵完成签到,获得积分10
36秒前
小南孩发布了新的文献求助10
37秒前
奔铂儿钯完成签到,获得积分10
38秒前
跳跃山柳完成签到,获得积分10
40秒前
量子星尘发布了新的文献求助10
42秒前
小南孩完成签到,获得积分10
45秒前
脑洞疼应助普鲁卡因采纳,获得10
51秒前
zhaoyaoshi完成签到 ,获得积分10
51秒前
chiazy完成签到,获得积分10
52秒前
智慧金刚完成签到 ,获得积分10
52秒前
汉堡包应助科研通管家采纳,获得10
52秒前
科研通AI2S应助科研通管家采纳,获得10
52秒前
52秒前
迪鸣完成签到,获得积分0
54秒前
浪费青春传奇完成签到 ,获得积分10
57秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022